These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

349 related articles for article (PubMed ID: 10382319)

  • 1. [Immunodeficiencies: an overview and various diagnostic difficulties].
    Fontán Casariego G
    Sangre (Barc); 1999 Apr; 44(2):101-6. PubMed ID: 10382319
    [No Abstract]   [Full Text] [Related]  

  • 2. [Primary immunodeficiencies. Clinical features and variant forms].
    Fontán Casariego G
    Allergol Immunopathol (Madr); 2001; 29(3):101-7. PubMed ID: 11434882
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Severe combined immunodeficiency with adenosine deaminase deficiency (author's transl)].
    Allepuz Llop N; Pellejá Pellejá J
    An Esp Pediatr; 1982 May; 16(5):421-5. PubMed ID: 7114620
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Primary immunodeficiencies: molecular aspects and treatment.
    Fischer A
    Bone Marrow Transplant; 1992; 9 Suppl 1():39-43. PubMed ID: 1354525
    [No Abstract]   [Full Text] [Related]  

  • 5. [Gene therapy of primary immunodeficiencies. Present and future].
    Serrano F; Laín de Lera T; González MA; García MJ; Abad JL; Bernad A
    Sangre (Barc); 1999 Apr; 44(2):143-53. PubMed ID: 10382324
    [No Abstract]   [Full Text] [Related]  

  • 6. Progress in primary immunodeficiency.
    Matsumoto S; Sakiyama Y; Ariga T; Gallagher R; Taguchi Y
    Immunol Today; 1992 Jan; 13(1):4-5. PubMed ID: 1739431
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Genotype is an important determinant of phenotype in adenosine deaminase deficiency.
    Hershfield MS
    Curr Opin Immunol; 2003 Oct; 15(5):571-7. PubMed ID: 14499267
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Gene therapy of primary immunodeficiencies.
    Fischer A; De Saint Basile G; Disanto JP; Hacein-Bey S; Sharara L; Cavazzana-Calvo M
    Adv Nephrol Necker Hosp; 1997; 26():107-20. PubMed ID: 8922128
    [No Abstract]   [Full Text] [Related]  

  • 9. [Severe combined immunodeficiencies: a case of adenosine-deaminase deficit].
    Macellaro P; Savarino A; Cucchi G; Lazzati A; Zuccotti GV
    Pediatr Med Chir; 2004; 26(3):191-5. PubMed ID: 16366403
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Genetic deficiencies of adenosine deaminase and purine nucleoside phosphorylase: overview, genetic heterogeneity and therapy.
    Hirschhorn R
    Birth Defects Orig Artic Ser; 1983; 19(3):73-81. PubMed ID: 6418227
    [No Abstract]   [Full Text] [Related]  

  • 11. Overview of biochemical abnormalities and molecular genetics of adenosine deaminase deficiency.
    Hirschhorn R
    Pediatr Res; 1993 Jan; 33(1 Suppl):S35-41. PubMed ID: 8433873
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of red cell transfusions, thymic hormone and deoxycytidine in severe combined immunodeficiency due to adenosine deaminase deficiency.
    Davies EG; Levinsky RJ; Webster DR; Simmonds HA; Perrett D
    Clin Exp Immunol; 1982 Nov; 50(2):303-10. PubMed ID: 6983936
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Current clinical immunology: a genetic and molecular perspective].
    Carrión F; Figueroa FE; Rodríguez C
    Rev Med Chil; 2000 Jun; 128(6):650-8. PubMed ID: 11016066
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Gene therapy for inherited immunodeficiencies.
    Howe S; Thrasher AJ
    Curr Hematol Rep; 2003 Jul; 2(4):328-34. PubMed ID: 12901330
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Severe phenotype of severe combined immunodeficiency caused by adenosine deaminase deficiency in a patient with a homozygous mutation due to uniparental disomy.
    Geelen J; Pfundt R; Meijer J; Verheijen FW; van Kuilenburg AB; Warris A; Marcelis C
    J Allergy Clin Immunol; 2013 Jul; 132(1):222-3. PubMed ID: 23260757
    [No Abstract]   [Full Text] [Related]  

  • 16. Adenosine deaminase deficiency: genotype-phenotype correlations based on expressed activity of 29 mutant alleles.
    Arredondo-Vega FX; Santisteban I; Daniels S; Toutain S; Hershfield MS
    Am J Hum Genet; 1998 Oct; 63(4):1049-59. PubMed ID: 9758612
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Seven novel mutations in the adenosine deaminase (ADA) gene in patients with severe and delayed onset combined immunodeficiency: G74C, V129M, G140E, R149W, Q199P, 462delG, and E337del. Mutations in brief no. 142. Online.
    Arrendondo-Vega FX; Santisteban I; Notarangelo LD; El Dahr J; Buckley R; Roifman C; Conley ME; Hershfield MS
    Hum Mutat; 1998; 11(6):482. PubMed ID: 10200056
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hematopoietic stem cell transplantation rescues the immunologic phenotype and prevents vasculopathy in patients with adenosine deaminase 2 deficiency.
    Van Eyck L; Hershfield MS; Pombal D; Kelly SJ; Ganson NJ; Moens L; Frans G; Schaballie H; De Hertogh G; Dooley J; Bossuyt X; Wouters C; Liston A; Meyts I
    J Allergy Clin Immunol; 2015 Jan; 135(1):283-7.e5. PubMed ID: 25457153
    [No Abstract]   [Full Text] [Related]  

  • 19. [Late onset of primary immune deficiencies].
    Bussone G; Mouthon L
    Presse Med; 2010 Feb; 39(2):196-207. PubMed ID: 19481902
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Spontaneous in vivo reversion to normal of an inherited mutation in a patient with adenosine deaminase deficiency.
    Hirschhorn R; Yang DR; Puck JM; Huie ML; Jiang CK; Kurlandsky LE
    Nat Genet; 1996 Jul; 13(3):290-5. PubMed ID: 8673127
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.